Search for any words: Search

                            

A North Central Cancer Treatment Group (NCCTG) Phase II Trial of VEGF Trap in Patients With Metastatic Breast Cancer (MBC) Previously Treated with an Anthracycline and/or a Taxane.

Hobday, T. ,  Rowland, K., Jr ,  Dueck, A. ,  Northfelt, D. ,  Lingle, W. ... -  ASCO Breast -  Breast Cancer Symposium -  2008  

Abstract -  Primary Endpoint -  Primary Analysis -  Breast -  NCCTG-N0537

Intrinsic subtype and response to paclitaxel in CALGB 9344 tissue microarrays

Nielsen, T. O. ,  Jewell, S. D. ,  Thor, A. D. ,  Gao, D. ,  Perou, C. M. ... -  ASCO Breast -  Breast Cancer Symposium -  2009  

Abstract -  Secondary Endpoint -  Primary Analysis -  Correl Sci NOS -  CALGB-159905 ,  C9344

ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor positive breast cancer

Olson, J. A. Jr ,  Babiera, G. V. ,  Unzeitig, G. ,  Marcom, P. K. ... -  ASCO Breast -  Breast Cancer Symposium -  2010  

Abstract -  Primary Endpoint -  Primary Analysis -  Breast -  ACOSOG-Z1031

Age, Race, BMI and Pathologic Complete Response Following Neoadjuvant Chemotherapy: An Analysis of Four Alliance Clinical Trials

Warner, Erica T. ,  Ballman, Karla V. ,  Strand, Carrie ... -  ASCO Breast -  J. Clin. Oncol. -  2015  

Abstract -  Primary Endpoint -  Primary Analysis -  Disparities -  A151426 ,  ACOSOG-Z1031 ,  ACOSOG-Z1041 ,  CALGB-40601 ,  CALGB-40603